Auctus Global Capital puts a high value on our relationships and contributes to the growth of the following organizations in various ways
IMS is a software and services company. The majority of their technical people have had long tenures with large established Medical Imaging Companies and bring a vast amount of experience and know-how to our service offerings.
Consumer Direct Care Network has led the industry in expanding choice and control since 1990.
In addition to financial management services and support brokerage, we can provide an array of caregiving models, including traditional agency home care and behavioral health. We have extensive experience with Medicaid, Medicare, private insurance, and supporting people who manage their own care.
LensGen™ is an ophthalmic medical device company developing an accommodating intraocular lens (AIOL) based solution to treat presbyopia and/ or cataracts
When we reach an age of 40 we begin to lose the ability to focus at near objects. The medical term for this condition is called presbyopia. Presbyopia is the loss of accommodation that occurs when the eye’s natural lens becomes less elastic due to aging.
Human accommodation works similar to the autofocus feature on a camera except human eyes adjust to distance and near objects through tiny muscle contractions within the eye that either thin or thicken the shape of the natural human lens. The LensGen™ AIOL is designed to fit inside the same location as the natural human lens and harness the tiny muscle contractions that occurs during natural accommodation in order to change the shape of the lens implant and restore youthful vision, thus eliminating the need for reading glasses at any age.
The LensGen™ AIOL is unique because it mimics the natural human lens and is designed to use the eye’s natural accommodation forces inside the eye to change shape and restore youthful vision to see clearly from distance to near and everything in between.
Founders Message: Through our personal experience with biomedical research, we saw many promising technologies fail to see clinical adoption because they were overly complex and impractical. We founded Laser Associated Sciences (LAS) in 2013 with the goal of creating simple and effective optical technologies that help guide physicians while treating patients.
LAS recently completed development of the FlowMet, a noninvasive blood flow monitor designed to give real-time feedback during vascular surgery. With the FlowMet and future optical monitoring technologies, LAS strives to make a difference in patient lives by improving their treatment while reducing healthcare costs.
The FlowMet blood flow measurement system incorporates LAS's optical technology into a simple and familiar clip-on formfactor.
The device can be placed on any extremity, including the finger or toe, and immediately begins outputting data in real-time.
LAS recently completed development of the FlowMet, a noninvasive blood flow monitor designed to give real-time feedback during vascular surgery. With the FlowMet and future optical monitoring technologies, LAS strives to make a difference in patient lives by improving their treatment while reducing healthcare costs.
The FlowMet system runs on a Surface tablet with a simple, easy-to-use touchscreen interface.
The software displays and records average blood flow and beat-to-beat cardiac flow waveforms continuously for up to 24 hours (while plugged into external power).
The perfusion indicator bar informs the user where the flow index may fall in the physiological range. The perfusion indicator is not designed to provide diagnostic information and is intended for research purposes only.
The flow index is calculated as the average flow between maximum (systolic) and minimum (diastolic) points of the cardiac cycle.
